Musculo-Skeletal-Disorders Osteoporosis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Osteoporosis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Osteoporosis Projects
--Asahi Kasei Corporation
--Abiogen Pharma S.p.A.
--DAIICHI SANKYO COMPANY, LIMITED
--Chugai Pharmaceutical Co Ltd
--Emisphere Technologies Inc
--Eli Lilly & Co
--Ligand Pharmaceuticals Inc
--Ipsen Ltd
--Novartis AG
--Merck & Co Inc
--OsteoCorp, Inc.
--Ono Pharmaceutical Co., Ltd.
--Radius
--erly NuVios, Inc.)
--ProStrakan Group plc
--Suntory Limited
--Roche Holdings Ltd
--Teijin Pharma Limited
--Taisho Pharmaceutical Co., Ltd.
--Zelos Therapeutics Inc.
--Wyeth

--Top Companies in early stage Osteoporosis Projects
--Addex Pharmaceuticals SA
--Acologix, Inc.
--Altea Therapeutics
--Alkermes Inc
--Biodel Inc.
--Bentley Pharmaceuticals Inc
--Chiesi Farmaceutici S.p.A
--Celgene Corporation
--Genentech Inc
--Emisphere Technologies Inc
--Hunter-Fleming Ltd
--GlaxoSmithKline plc
--Karo Bio AB
--Japan Tobacco Inc.
--Medivir AB
--Ligand Pharmaceuticals Inc
--Takeda Pharmaceutical Company Limited
--ProStrakan Group plc
--Velcura Therapeutics, Inc
--TAP Pharmaceutical Products Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View